ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Visugromab Biosimilar - Anti-GDF15 Antibody - BSA and Azide free (A339243)

Recombinant humanized monoclonal antibody to GDF15 for use as a research grade Visugromab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Visugromab Biosimilar - Anti-GDF15 Antibody - BSA and Azide free
Description
Recombinant humanized monoclonal antibody to GDF15 for use as a research grade Visugromab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG4
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
GDF-15, Growth/differentiation factor 15, Macrophage inhibitory cytokine 1, MIC-1, MIC1, NAG-1, NRG-1, NSAID-activated gene 1 protein, NSAID-regulated gene 1 protein, PDF, PLAB, Placental bone morphogenetic protein, Placental TGF-beta, Prostate differentiation factor, PTGFB
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Visugromab Biosimilar - Anti-GDF15 Antibody - BSA and Azide free (A339243)? Please let us know so that we can list the citation on this page.

Alternative products to Visugromab Biosimilar - Anti-GDF15 Antibody - BSA and Azide free (A339243)

Proteins predicted to interact with GDF15

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
96% Relevancy Score
95.8% Relevancy Score
88.5% Relevancy Score
87.7% Relevancy Score
76.2% Relevancy Score
74.6% Relevancy Score
72.2% Relevancy Score
68.5% Relevancy Score